Neuroscience Drug Development: How Novel Applications of AI Could Meaningfully Disrupt Traditional Development Strategies, Upcoming Webinar Hosted by Xtalks

In this free webinar, see how AI can deliver practical value across the CNS trial journey today in eCOA, imaging and rater training. Attendees will gain insight into the role for AI-supported vocal biomarkers to augment and accelerate psychiatric drug development. The featured speakers will discuss the role for AI-enabled MADRS interview quality analysis for rater training and rater oversight during the conduct of psychiatric studies. Attendees will learn how comprehensive and responsible AI use throughout the imaging workflow enhances data quality, patient safety and unlocks new biomarkers for neuro-imaging trials. The speakers will share insights into the responsible use framework for development and deployment of AI in clinical trials, including training, validation, human oversight and awareness of the regulatory environment.

TORONTO, April 22, 2026 /PRNewswire/ -- Neuroscience trials require high-precision, sensitive endpoint measurements, yet sponsors often face challenges with subjective endpoints, rater variability, patient burden and time-intensive data analysis.

This webinar will explore how AI can help address these challenges across the neuroscience trial journey. When developed and applied responsibly, AI can improve data quality and precision, enhance consistency in clinical assessments across multiple sites and support the identification of additional data insights beyond human expert capabilities.

Clario's scientific and AI experts will share how AI-enabled solutions are being applied in neuroscience trials today, including novel vocal biomarkers, MADRS rater training and quality oversight and innovative imaging analysis methodologies. Attendees will leave with a clearer understanding of where AI can add meaningful value in CNS trials.

Register for this webinar to discover how AI can bring greater precision, insight and confidence to neuroscience trial execution.

Join experts from Clario, Todd Rudo (Moderator), MD, EVP, Chief Medical Officer; Mark Opler, PhD, Chief Research Officer, eCOA Neuroscience; Alex Boudreau, Director, AI; and Joël Schaerer, PhD, Senior Director, Imaging AI, for the live webinar on Wednesday, May 13, 2026, at 11am EDT (5pm CEST/EU-Central).

For more information, or to register for this event, visit Neuroscience Drug Development: How Novel Applications of AI Could Meaningfully Disrupt Traditional Development Strategies.

ABOUT XTALKS

Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks